Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Motivating HIV+ Women: Risk Reduction and ART Adherence (KHARMA)

This study has been completed.
Information provided by (Responsible Party):
Marcia McDonnell Holstad, DSN, FNP-BC, Emory University Identifier:
First received: November 14, 2005
Last updated: September 13, 2013
Last verified: September 2013